HSDTHELIUS MEDICAL TECHNOLOGIES...

Nasdaq heliusmedical.com


$ 1.42 $ 0.06 (4.38 %)    

Wednesday, 22-May-2024 15:59:15 EDT
QQQ $ 454.82 $ -0.09 (-0.02 %)
DIA $ 398.57 $ -2.12 (-0.53 %)
SPY $ 530.36 $ -1.53 (-0.29 %)
TLT $ 91.26 $ 0.11 (0.12 %)
GLD $ 225.37 $ -4.12 (-1.84 %)
$ 1.43
$ 1.38
$ 0.00 x 0
$ 0.00 x 0
$ 1.35 - $ 1.42
$ 1.32 - $ 14.44
124,345
na
1.17M
$ 1.40
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-28-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-09-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-14-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 03-10-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-12-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 03-12-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 03-14-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 03-12-2018 12-31-2017 10-K
27 11-09-2017 09-30-2017 10-Q
28 08-11-2017 06-30-2017 10-Q
29 05-16-2017 03-31-2017 10-Q
30 11-14-2016 09-30-2016 10-Q
31 08-15-2016 06-30-2016 10-Q
32 06-28-2016 03-31-2016 10-K
33 02-16-2016 12-31-2015 10-Q
34 11-16-2015 09-30-2015 10-Q
35 08-14-2015 06-30-2015 10-Q
36 06-29-2015 03-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 helius-medical-technologies-pons-now-available-on-the-va-federal-supply-schedule-and-general-services-administration-advantage-contracts-pons-system-item--s1-001-02-priced-at-2384372-and-the-pons-mouthpiece-item--m1-001-priced-at-734497

-- Approval provides U.S. veterans and other U.S. government agency employees who suffer gait and balance impairment due to mul...

 helius-medical-tech-q1-2024-gaap-eps-308-misses-270-estimate-sales-135000k-beat-130500k-estimate

Helius Medical Tech (NASDAQ:HSDT) reported quarterly losses of $(3.08) per share which missed the analyst consensus estimate of...

 reported-earlier-helius-medical-technologies-prices-64m-public-offering-of-804999-class-a-common-shares-and-2047222-pre-funded-warrants

Helius Medical Technologies a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance ...

 helius-medical-technologies-announces-preliminary-cms-payment-determination-of-reimbursement-for-portable-neuromodulation-stimulator

-- The Centers for Medicare & Medicaid Services (CMS) released its preliminary Medicare payment determinations for the PoNS...

 helius-medical-technologies-expands-stroke-clinical-program-with-participation-of-shepherd-center

-- Helius Medical and Shepherd Center partner on a study that aims at rehabilitating walking mobility in people recovering from...

 why-is-nano-cap-helius-medical-stock-trading-higher-on-wednesday

Helius Medical partners with Lovell Govt Services to provide PoNS device to federal healthcare systems. PoNS, a short-term trea...

Core News & Articles
Market-Moving News for April 3rd
04/03/2024 12:40:57

ABIO: 165% | ARCA Biopharma shares are trading higher after the company and Oruka Therapeutics announced a merger agreement. L...

 helius-medical-technologies-inc-announces-partnership-with-lovell-government-services-to-expand-reach-of-pons-therapy

Helius Medical Technologies, Inc. (NASDAQ:HSDT) ("Helius" or the "Company"), a neurotech company focused on del...

 helius-medical-tech-q4-2023-gaap-eps-147-beats-377-estimate-sales-134000k-miss-246333k-estimate

Helius Medical Tech (NASDAQ:HSDT) reported quarterly losses of $(1.47) per share which beat the analyst consensus estimate of $...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION